CVS Health (NYSE:CVS) Price Target Raised to $110.00

CVS Health (NYSE:CVS) had its price objective boosted by TD Cowen from $105.00 to $110.00 in a research note published on Monday morning, MarketBeat reports. They currently have a buy rating on the pharmacy operator’s stock.

Other analysts have also issued reports about the company. DA Davidson lifted their price target on CVS Health from $80.00 to $100.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Wolfe Research lowered their price target on CVS Health from $100.00 to $97.00 and set an “outperform” rating on the stock in a research note on Monday, March 2nd. The Goldman Sachs Group lifted their price target on CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. Truist Financial lifted their price target on CVS Health from $98.00 to $102.00 and gave the stock a “buy” rating in a research note on Thursday, May 7th. Finally, Sanford C. Bernstein raised CVS Health from a “market perform” rating to an “outperform” rating and lifted their price target for the stock from $91.00 to $94.00 in a research note on Thursday, March 12th. Twenty-two research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average target price of $97.00.

CVS Health Stock Up 3.1%

CVS Health stock opened at $98.14 on Monday. The stock has a market capitalization of $125.22 billion, a PE ratio of 43.24, a price-to-earnings-growth ratio of 0.93 and a beta of 0.60. CVS Health has a 12 month low of $58.35 and a 12 month high of $98.22. The business has a 50 day simple moving average of $78.07 and a 200-day simple moving average of $78.36. The company has a debt-to-equity ratio of 0.78, a current ratio of 0.87 and a quick ratio of 0.66.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 EPS for the quarter, beating analysts’ consensus estimates of $2.21 by $0.36. The business had revenue of $100.43 billion during the quarter, compared to analysts’ expectations of $94.99 billion. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The business’s revenue was up 6.2% compared to the same quarter last year. During the same period in the previous year, the business earned $2.25 earnings per share. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, analysts anticipate that CVS Health will post 7.46 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 2.7%. The ex-dividend date of this dividend was Thursday, April 23rd. CVS Health’s dividend payout ratio is 117.18%.

Insider Activity at CVS Health

In other news, EVP Tilak Mandadi sold 69,551 shares of the company’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the transaction, the executive vice president owned 10,133 shares of the company’s stock, valued at $907,714.14. This represents a 87.28% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.85% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On CVS Health

Several large investors have recently modified their holdings of the business. Sei Investments Co. raised its holdings in shares of CVS Health by 17.4% in the 2nd quarter. Sei Investments Co. now owns 905,715 shares of the pharmacy operator’s stock valued at $62,474,000 after buying an additional 134,535 shares during the period. The Manufacturers Life Insurance Company raised its holdings in shares of CVS Health by 1.2% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,121,377 shares of the pharmacy operator’s stock valued at $77,353,000 after buying an additional 13,329 shares during the period. Treasurer of the State of North Carolina raised its holdings in shares of CVS Health by 1.3% in the 2nd quarter. Treasurer of the State of North Carolina now owns 585,073 shares of the pharmacy operator’s stock valued at $40,358,000 after buying an additional 7,588 shares during the period. HUB Investment Partners LLC raised its holdings in shares of CVS Health by 25.0% in the 2nd quarter. HUB Investment Partners LLC now owns 15,063 shares of the pharmacy operator’s stock valued at $1,039,000 after buying an additional 3,011 shares during the period. Finally, Alliancebernstein L.P. raised its holdings in shares of CVS Health by 8.0% in the 2nd quarter. Alliancebernstein L.P. now owns 1,609,404 shares of the pharmacy operator’s stock valued at $111,017,000 after buying an additional 119,439 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Analysts at JPMorgan and Sanford C. Bernstein raised their price targets on CVS Health, reinforcing confidence that the stock still has room to run after strong quarterly results. Analyst target raises and company news
• Positive Sentiment: CVS Health won Gold in Enterprise AI and Silver in Customer Experience AI at the 2026 Stevie Awards, highlighting continued progress in using technology to improve operations and customer service. CVS Health wins awards for AI innovation
• Positive Sentiment: MinuteClinic is expanding its clinically supervised weight-loss and preventive care offerings, which supports CVS’s broader strategy to grow higher-value healthcare services. MinuteClinic weight-loss program
• Positive Sentiment: Omnicare, a CVS subsidiary, received court approval to sell its business to GenieRx, removing uncertainty around a distressed asset and potentially simplifying CVS’s portfolio. Reuters Omnicare sale approval

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.